Mill Creek Capital Advisors LLC Sells 218 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mill Creek Capital Advisors LLC lowered its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,767 shares of the exchange traded fund’s stock after selling 218 shares during the quarter. Mill Creek Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $609,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $29,000. Avior Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC lifted its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. Finally, ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $44,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $90.34 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company’s 50-day moving average is $92.40 and its 200 day moving average is $96.38. The firm has a market capitalization of $6.89 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.